Bg pattern

ACTUATOS 35 mg ORAL SOLUTION IN SACHETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ACTUATOS 35 mg ORAL SOLUTION IN SACHETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Leaflet: information for the user

Actúatos 35 mgsyrup in sachets

dry extract ofHedera helix L.(ivy)

Read the entire leaflet carefully before starting to take this medication because it contains important information for you.

Follow the administration instructions of the medication contained in this leaflet or as indicated by your doctor or pharmacist exactly.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 7 days.

Contents of the leaflet

  1. What is actúatos and what is it used for

2.

  1. How to take actúatos
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

4.

  1. Storage of actúatos

6.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

1. What is actúatos and what is it used for

Actúatos 35 mg syrup in sachets is a plant-based medication used as an expectorant for productive cough in adults, adolescents, and children from 6 years old.

2. What you need to know before taking actúatos

Do not take actúatos:

  • If you are allergic to ivy (Hedera helix L.), to plants of the Araliaceae family, or to any of the other components of this medication (listed in section 6).
  • Do not administer to children under 2 years old, as there is a risk that expectorants may worsen respiratory symptoms.

Warnings and precautions:

Consult your doctor or pharmacist before starting to take this medication.

You should consult with your doctor or pharmacist in cases of dyspnea (difficulty breathing), fever, or purulent sputum.

Cautions are recommended in patients with gastritis or gastric ulcers.

In case of worsening symptoms or if no improvement occurs after 7 days of starting treatment, it should be discontinued and a doctor should be consulted.

Children

This medication should not be administered to children from 2 to 5 years old, as it cannot be dosed adequately; there are other formulations more suitable for this age group.

Taking actúatos with other medications:

Inform your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.

Pregnancy, breastfeeding, and fertility:

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.

Pregnancy and breastfeeding:

The safety of this medication during pregnancy and breastfeeding has not been established; therefore, its use is not recommended in these circumstances.

Fertility:

No data are available on fertility.

Consult your doctor or pharmacist before using any medication.

Driving and using machines

No studies have been conducted on the effects on the ability to drive and use machines.

Actúatoscontains sorbitol.

This medication contains 1.925 mg of sorbitol in each 5 ml sachet (385 mg per ml).

Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to certain sugars or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult your doctor before taking this medication.

Sorbitol may cause gastrointestinal upset and a mild laxative effect.

3. How to take actúatos

Follow the administration instructions of this medication contained in this leaflet or as indicated by your doctor or pharmacist exactly. If in doubt, ask your doctor or pharmacist.

The recommended dose is:

  • Adolescents and adults: 1 sachet of 5 ml of syrup, 2 or 3 times a day (equivalent to 70-105 mg daily of dry extract of ivy leaf).
  • Children between 6 and 11 years old:1 sachet of 5 ml of syrup, 2 times a day (equivalent to 70 mg daily of dry extract of ivy leaf).

This medication should not be administered to children from 2 to 5 years old, as it cannot be dosed adequately; there are other formulations more suitable for this age group.

If you think the action of this medication is too strong or too weak, tell your doctor or pharmacist.

This medication is taken orally.

For more details on using the sachets, follow the diagrams below:

Press the sachet gently before using it, as shown.

Hand pinching the skin at an angle showing the subcutaneous injection site with the thumb and index finger

Hold the sachet firmly and tear it along the indicated lines.

Hands holding a pen with a needle and pressing on the skin to administer an injection

Swallow the medication, squeezing the sachet until it is empty.

Hand holding a device with an exposed blade to cut the skin or tissue with care

You should consult a doctor if it worsens or does not improve after a week of treatment.

If you take more actúatosthan you should

Overdose may cause nausea, vomiting, diarrhea, and agitation.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 915 620 420, indicating the medication and the amount ingested.

If you forget to takeactúatos:

Do not take a double dose to make up for the forgotten dose.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone may experience them.

Unknown frequency: gastrointestinal-type reactions such as nausea, vomiting, and diarrhea, and allergic reactions such as hives, skin rashes, difficulty breathing, and anaphylactic reaction have been reported.

If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this leaflet.

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of actúatos

Keep this medication out of the sight and reach of children.

No special storage conditions are required.

Do not use this medication after the expiration date shown on the packaging, after "EXP". The expiration date is the last day of the month indicated.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of actúatos 35 mg syrup in sachets:

  • The active ingredient is: dry extract of Hedera helixleaf.

5 ml of actúatos 35 mg syrup in sachets contains 35 mg of dry extract of Hedera helix L. leaf (4-8:1), extraction solvent: ethanol 30% m/m.

  • The other components are: purified water, potassium sorbate, citric acid, non-crystallizable liquid sorbitol (E-420), xanthan gum, and cherry flavor. See section 2 "Actúatos contains sorbitol"

Appearance of the product and package contents:

Actúatos 35 mg syrup in sachets is presented in sachets containing 5 ml of syrup.

Monodose sachets composed of a complex aluminum layer (PET/Aluminum/PE/PET/PE). Packages with 20 monodose sachets.

Marketing authorization holder and manufacturer:

Marketing authorization holder

Adventia Pharma, S.L.

Calle Viera y Clavijo, 30, 2º

35002 Las Palmas de Gran Canaria (Spain)

Manufacturer:

Kern Pharma S.L.

Venus, 72 - Pol. Ind. Colón II

08228 Terrassa - Barcelona

Spain

You can request more information about this medication by contacting the local representative of the marketing authorization holder:

Actúa Pharma, S.L.

Calle Viera y Clavijo, 30, 2º

35002 Las Palmas de Gran Canaria (Spain)

Date of the last revision of this leaflet: June 2025

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for ACTUATOS 35 mg ORAL SOLUTION IN SACHETS

Discuss questions about ACTUATOS 35 mg ORAL SOLUTION IN SACHETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (18)
Doctor

Muhammad Tayyab Altaf

General medicine 3 years exp.

Dr. Muhammad Tayyab Altaf is a primary care physician with extensive international experience, offering online consultations for adults and children. His background includes clinical practice in Policlinico San Matteo Hospital Pavia in Italy, Mount Sinai Hospital in New York, United States and other healthcare settings, allowing him to manage a wide range of acute and chronic medical conditions with confidence and clarity.

His clinical expertise spans multi-system conditions, preventive care and long-term management of chronic diseases. Dr. Altaf combines hands-on experience with a strong research background in both medical and surgical fields, enabling him to provide accurate assessments and structured, evidence-based treatment plans. Patients value his ability to explain diagnoses clearly, outline next steps and support them in making informed healthcare decisions.

Online consultations with Dr. Altaf are suitable for many everyday and acute situations where a timely medical opinion can help determine the safest next steps. He evaluates and treats conditions affecting the cardiovascular, respiratory, gastrointestinal, neurological, haematological and endocrine systems. Common examples include:

  • hypertension and other blood pressure issues
  • ischaemic heart disease and angina
  • asthma, COPD and emphysema
  • pneumonia and lung fibrosis
  • gastroenteritis and digestive infections
  • liver conditions, including alcohol-related disease
  • epilepsy, seizures and post-stroke symptoms
  • dementia and cognitive decline
  • anaemia and other haematological changes
  • diabetes, thyroid disorders and pituitary disease
Many patients reach out when they experience new or worsening symptoms, fluctuations in blood pressure, non-severe chest discomfort, breathing symptoms, digestive issues, suspected infections, chronic fatigue or concerns that affect daily life. He also helps patients understand test results, adjust existing treatment plans and navigate long-term health strategies safely and effectively.

When clinically appropriate, Dr. Altaf can also provide health and fitness certificates, including documentation required for physical activity, sports participation or gym use, based on the patient’s health status and medical indications.

Some conditions are not suitable for online care. Severe chest pain, loss of consciousness, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack require immediate attention from local emergency services. Dr. Altaf prioritises patient safety and will guide you accordingly if your situation needs urgent in-person care.

In all consultations, Dr. Muhammad Tayyab Altaf focuses on clear communication, accurate diagnosis and patient-centred decision-making. His approach ensures that individuals and families feel informed, supported and confident in their next steps, no matter where they are.

Camera Book a video appointment
€50

Frequently Asked Questions

Is a prescription required for ACTUATOS 35 mg ORAL SOLUTION IN SACHETS?
ACTUATOS 35 mg ORAL SOLUTION IN SACHETS does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ACTUATOS 35 mg ORAL SOLUTION IN SACHETS?
The active ingredient in ACTUATOS 35 mg ORAL SOLUTION IN SACHETS is Hederae helicis folium. This information helps identify medicines with the same composition but different brand names.
Who manufactures ACTUATOS 35 mg ORAL SOLUTION IN SACHETS?
ACTUATOS 35 mg ORAL SOLUTION IN SACHETS is manufactured by Adventia Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ACTUATOS 35 mg ORAL SOLUTION IN SACHETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ACTUATOS 35 mg ORAL SOLUTION IN SACHETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ACTUATOS 35 mg ORAL SOLUTION IN SACHETS?
Other medicines with the same active substance (Hederae helicis folium) include ABRILAR SYRUP, ACTUATOS 7 mg/ml SYRUP, CINFAHELIX SYRUP. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media